We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+17.39%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.66B
AUM Growth
+$537M
Cap. Flow
-$23.3M
Cap. Flow %
-0.5%
Top 10 Hldgs %
6.44%
Holding
1,468
New
106
Increased
604
Reduced
314
Closed
113

Top Buys

Rank Stock Value
1
XRX icon
Xerox
XRX
+$14.1M
2
DAN icon
Dana Inc
DAN
+$12.5M
3
OPEN icon
Opendoor
OPEN
+$10.6M
4
CSCO icon
Cisco
CSCO
+$7.51M
5
JBLU icon
JetBlue
JBLU
+$7.32M

Sector Composition

Rank Sector Weight
1 Financials 26.7%
2 Consumer Discretionary 12.75%
3 Industrials 12.29%
4 Technology 10.9%
5 Healthcare 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMTX icon
951
Aemetis
AMTX
$124M
$472K 0.01%
90,000
+50,000
+125% +$236K
PRAX icon
952
Praxis Precision Medicines
PRAX
$10.1B
$471K 0.01%
21,152
+7,705
+57% +$139K
SPIR icon
953
Spire Global
SPIR
$555M
$469K 0.01%
60,000
+19,000
+46% +$97.1K
LAB icon
954
Standard BioTools
LAB
$314M
$469K 0.01%
212,000
AAME icon
955
Atlantic American Corp
AAME
$31.2M
$468K 0.01%
196,521
-5,039
-3% -$9.49K
CBIO
956
Crescent Biopharma
CBIO
$626M
$465K 0.01%
1,972
+250
+15% +$38.9K
NCSM icon
957
NCS Multistage Holdings
NCSM
$125M
$461K 0.01%
26,759
+1,344
+5% +$19.5K
INOD icon
958
Innodata
INOD
$2.04B
$460K 0.01%
56,555
LFMD icon
959
LifeMD
LFMD
$172M
$460K 0.01%
55,500
-52,800
-49% -$380K
MACK
960
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$459K 0.01%
34,200
TPIC
961
DELISTED
TPI Composites
TPIC
$455K 0.01%
+110,000
New +$286K
CLPT icon
962
ClearPoint Neuro
CLPT
$433M
$455K 0.01%
66,992
EPM icon
963
Evolution Petroleum
EPM
$131M
$454K 0.01%
78,133
-8,784
-10% -$53.8K
RRGB icon
964
Red Robin
RRGB
$152M
$453K 0.01%
36,300
-7,200
-17% -$67.2K
LENZ
965
LENZ Therapeutics
LENZ
$168M
$453K 0.01%
24,679
RDW icon
966
Redwire
RDW
$3.25B
$452K 0.01%
158,500
VIGL
967
DELISTED
Vigil Neuroscience
VIGL
$449K 0.01%
+132,964
New +$684K
ELA icon
968
Envela
ELA
$446M
$447K 0.01%
92,000
SAMG icon
969
Silvercrest Asset Management
SAMG
$79.9M
$447K 0.01%
26,277
TCMD icon
970
Tactile Systems Technology
TCMD
$665M
$445K 0.01%
31,100
ANVS icon
971
Annovis Bio
ANVS
$80M
$441K 0.01%
23,600
ARAY icon
972
Accuray
ARAY
$34M
$439K 0.01%
155,300
-21,000
-12% -$57.3K
AP icon
973
Ampco-Pittsburgh
AP
$193M
$439K 0.01%
160,632
STXS icon
974
Stereotaxis
STXS
$141M
$437K 0.01%
249,700
OPTN
975
DELISTED
OptiNose
OPTN
$436K 0.01%
22,540

Similar funds

Bridgeway Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Bridgeway Capital Management held 1,468 positions worth $4.66B, up 13% from $4.12B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.

Bridgeway Capital Management's Q4 2023 filing shows 106 new, 604 increased, 314 reduced and 113 closed positions. Its largest new stake was Xerox: 953,092 shares worth $17.5M. The largest sale was Textainer Group Holdings limited, an estimated $19.1M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q4 2023 buy was Xerox: 953,092 shares worth $17.5M.
  • Bridgeway Capital Management added most to Opendoor in Q4 2023, an estimated $10.6M increase.
  • Bridgeway Capital Management's biggest Q4 2023 reduction was Textainer Group Holdings limited, cutting an estimated $19.1M.
  • Bridgeway Capital Management fully exited VERITIV CORPORATION in Q4 2023, selling an estimated $13M.
  • Bridgeway Capital Management's ten largest holdings make up 6.4% of its $4.66B portfolio in Q4 2023.
  • Bridgeway Capital Management opened 106 new positions and closed 113 in Q4 2023.
  • Bridgeway Capital Management's portfolio value rose 13% quarter-over-quarter to $4.66B.

Based on Bridgeway Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.